News

Centogene AG, Germany and Mikrogen, Turkey, are pleased to announce a long-term strategic partnership. Read more in our news!

Centogene is thrilled to announce the launch of construction for its new headquarters in Rostock. Read more in our news section!

CENTOGENE is one of the few companies worldwide with the ability & expertize to offer whole genome sequencing (WGS). The addition of WGS to our test portfolio means that we provide a very unique service: from hot spot mutation testing up to whole genome sequencing at one dedicated facility.

Targeted panels screen for germline mutations in genes that determine an inherited predisposition to, or increased risk for, certain cancers.

Receiving high quality samples is critical for the genetic diagnostic process. An important consideration when requesting genetic testing is how to ensure that your patient‘s sample will reach the laboratory in good condition.

While celebrating the Rare Disease Day 2015, Centogene and Iran’s State Welfare Organization and Rare Diseases Foundation signed in Tehran an agreement to strengthen joint efforts, providing support for patients with rare diseases in Iran.

Active in over 90 countries, we are now proud to announce that we are joining forces with GlobeMed Lebanon. Hence, we can ensure that all patients will have access to premium genetic diagnostics services.

At the prestigious Step Award in Frankfurt on December the 2nd, CENTOGENE succeeded in two categories. In the areas of Finance as well as Market/Customer CENTOGENE convinced the jury and left the other candidates behind.

Centogene is pleased to announce beneficiary of its Rare Disease Day Quiz 2014. It is the Regroupement québécois des maladies orphelines (RQMO)/Quebec Coalition of Orphan Diseases, that offers a professional information and support through its “Rare Disease Info Portal”.

Centogene announces the transfer of its Canadian business to LifeLabs Medical Laboratory Services (“LifeLabs”), the largest laboratory throughout Canada. Centogene will establish a state-of-the-art genetic laboratory in Ontario, enabling LifeLabs to become the leader with a genetics diagnostic center of excellence in Canada.

Prof Arndt Rolfs, MD, Chief Medical Director of Centogene, discussed with Suzanne Radford at her radio broadcast “Eye on Health”, Radio Dubai Today: dubaieye1038, about the basic aspects of genetic testing, its huge medical benefit physicians and patients will receive as well as treatment options for rare diseases and newborn screening.

Centogene is committed to providing the highest level of quality. A part of that commitment is participating in multiple Proficiency Testing Schemes that test our scientists and technical personnel competency and provide the needed information to continuously monitor the laboratory performance.

CENTOGENE is pleased to announce the start of its operations in India through its subsidiary, Centogene India Private Limited. Physicians and patients in India will be able to access advanced genetic testing for more than 1,700 disorders including prenatal diagnosis.

While several genes have been identified to cause Parkinson’s disease (PD), monogenic forms explain only a small proportion of cases. We report clinical and genetic results in a large family with late-onset autosomal dominant PD.

In an effort to make testing easier and more accessible, Centogene now offers PCR-analysis of every gene in our catalogue from dried blood spots (DBS) collected on filter cards.